Ipopema Securities SA (IPE)
Warsaw Stock Exchange · Poland · prices in PLN · close of 27 Oct 2026
Key indicators
| Last close | PLN 8.380 |
|---|---|
| 52-week range | 3.050 – 10.150 |
| Return, 1 month / 3 months | −8.5% / +11.7% |
| Return, 1 year / 3 years | +184.5% / +235.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 37 |
| Volatility (1 year) | 34.4% |
| Worst drawdown (1 year) | -16.4% |
| Average daily value traded | 0.10M PLN |
| Dividend yield | 7.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ipopema Securities is a Polish financial services firm based in Warsaw that provides brokerage and investment banking services. It executes securities trades for institutional and individual clients, offers equity research and sales, and advises companies on corporate finance matters such as capital raising and mergers. Its customers include domestic and international investors as well as companies seeking advisory support on transactions and market access.
Ipopema Securities SA trades under the code IPE on the Warsaw Stock Exchange in Poland, with its price quoted in Polish zloty (PLN). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Ipopema Securities SA (IPE) trades on the Warsaw Stock Exchange in Poland. It last closed at PLN 8.380 on 27 October 2026.
Its price-based Market X-Ray is 80 out of 100 (a strong price profile), ranking 34 of 580 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 184.5% and over the last three months it rose 11.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Warsaw Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 25.2% | ||
| From 52-week high | -16.2% | ||
| Momentum | 89 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 11.7% | ||
| 6-month return | 41.3% | ||
| 12-month return, skipping the last month | 210.9% | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.4% | ||
| Liquidity | 67 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.10M PLN | ||
| Zero-volume days | 0.0% | ||
| Income | 73 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 7.2% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.7% |
|---|---|
| 1 month | −8.5% |
| 3 months | +11.7% |
| 6 months | +41.3% |
| 1 year | +184.5% |
| 3 years | +235.6% |
| 5 years | +287.3% |
Signals
| 50-day / 200-day average | 9.045 / 6.693 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.281 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Jul 2026 | PLN 0.6000 |
| 26 Jun 2025 | PLN 0.2100 |
| 22 May 2024 | PLN 0.3000 |
| 1 Jun 2023 | PLN 0.1500 |
| 2 Jun 2022 | PLN 0.3100 |
| 29 Jun 2021 | PLN 0.3700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Warsaw Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.